Searchable abstracts of presentations at key conferences in endocrinology

ea0013p340 | Thyroid | SFEBES2007

Pyogenic thyroiditis with hyperthyroxinaemia

Magee Glynis , McConnell Mae

A 14 year old girl presented with a two week history of painful throat and ears after having been previously treated with a course of antibiotics. She also complained of neck swelling and on further questioning admitted to increasing sweating and weight loss.On examination she had pyrexia of 38.9  °C and a tachycardia. A postural tremor was elicited and an enlarged, smooth, tender goitre. Initial laboratory investigations were fT4 56.2 and TSH ...

ea0104p114 | Diabetes & Metabolism | SFEIES24

The importance of identifying the correct type of diabetes: a rare case of bardet-biedl syndrome type 3

Bonanos Stathis , McConnell Mae

Bardet-Biedl affects 1/100,000 people. Biallelic loss of function pathogenic variants in over 26 genes may be due to autosomal recessive inheritance. Diagnosis is clinical, with genetic testing confirmation. Presenting features include retinal cone-rod dystrophy, obesity, polydactyly, cognitive impairment, hypogonadism, genitourinary abnormalities, monogenic diabetes, hypothyroidism, polycystic ovarian and metabolic syndrome. We present a rare case of Bardet-Biedl type 3, with...

ea0037ep1128 | Endocrine tumours | ECE2015

A unique case of hyperparathyroidism-jaw tumour syndrome due to a previously unreported pathogenic duplication mutation of CDC73 gene

Bogusz Pawel , McConnell Elizabeth Mae , McConnell Vivienne , Korda Marian

Hyperparathyroidism-jaw tumour syndrome (HPT-JT) is a rare autosomal dominant condition characterized by primary hyperparathyroidism (<90%) as a result of parathyroid adenoma or carcinoma (10–15%), ossifying fibromas of mandible and maxilla (30–40%), renal lesions (20%) most commonly cysts and benign and malignant uterine tumours and caused by germline CDC73 pathogenic gene mutations. Currently only 200 cases reported in medical literature. His management has pro...

ea0104p205 | Thyroid | SFEIES24

Selenium prescribing for thyroid eye disease in NI – the exponential rise

Aamir Shahzad Muhammad , Nugent Ailish , Hunter Amy , Lewis Anthony , Loughrey Ben , Ahmed Doua , Casey Geraldine , McHenry Claire , Courtney Hamish , Wallace Helen , Wallace Ian , Lindsay John , Darrat Milad , Johnston Philip , Haq Rizwan , D'Arcy Robert , Kamalarajah Sri , Hunter Steven , White Steven , Graham Una , McNabb Bernadette , McElwaine Fred , McMullan Paul , Harper Roy , Elhassan Samah , Shakeel Majeed Muhammad , Mustafa Shaikh Ghulam , Neely Andrew , Todd Anna , Sandhu Farooq , Smyth Jayna , Bradley Una , McConnell Mae , Kennedy Adele , Hameed Ali , Hamill Connor , Rooney Des , McKeever Edward , McCracken Emma , Black Neil , Kelly Rhys , Cartmill Barry , Bonanos Efstathios , Gordon Aileen , Woodside Jayne , Mullan Karen

Selenium (Se) supplementation is recommended by the European Group (EUGOGO) for mildly active TED (200 mg/day for six-months) based on a seminal RCT which reported slowing of disease progression vs placebo. Treatment in Se deficient geographical areas may be particularly important. We recently reported Se deficiency in a cohort of 240 pregnant women in NI. The TEAMeD-NI group was set up in 2019 as part of the UK-wide quality improvement program to take a proactive approach to ...